Jilin Yatai Bio-pharmaceutical

Jilin Yatai Bio-pharmaceutical is a specialized biotechnology subsidiary of the Jilin Yatai Group, located in the Changchun High-tech Industrial Development Zone. The company focuses on the research, development, and production of biological products, most notably human vaccines and recombinant proteins. Its key commercial offerings include the Vero cell-based rabies vaccine and recombinant human erythropoietin (EPO). As a significant player in the Jilin provincial pharmaceutical cluster, the company maintains large-scale GMP manufacturing facilities and contributes to the group's broader healthcare portfolio. The company integrates modern biotechnological platforms with large-scale production to address infectious diseases and hematological conditions. It is recognized as a key high-tech enterprise within the National Biological Industry Base in Changchun.